Statements - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Ligand Pharmaceuticals Incorporated

LGND

Valuace

Růst

Zdraví

100

Cena

$ 200.03

-3.11 (-1.59%)

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total Revenues	268.1	268.1	167.1	131.3	196.2	277.1	186.4	120.3	251.5	141.1	109.0	71.9	64.5	49.0	31.4	30.0	23.5
Cost of Revenues	6.6	6.6	11.1	35.0	52.8	62.2	30.4	11.3	6.3	5.4	5.6	5.8	9.1	5.7	3.6	4.9	0.0
Gross Profit	261.5	261.5	156.1	96.3	143.4	215.0	156.0	108.9	245.1	135.7	103.4	66.1	55.4	43.2	27.8	25.1	23.5

Revenue	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Total Revenues	59.7	115.5	47.6	45.3	42.8	51.8	41.5	31.0	28.1	32.9
Cost of Revenues	-26.0	24.8	2.9	4.8	2.8	12.5	-15.3	11.1	1.7	3.5
Gross Profit	85.7	90.6	44.7	40.5	40.0	39.3	56.9	19.9	26.4	29.4

Operating Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
R&D Expenses	0.0	0.0	0.0	24.5	36.1	69.0	59.4	55.9	27.9	26.9	21.2	13.4	12.1	9.3	10.8	10.3	22.1
Selling General & Admin Expenses	0.0	0.0	0.0	52.8	70.1	57.5	64.4	41.9	37.7	28.7	26.6	24.4	22.6	18.0	16.1	15.0	29.7
Depreciation & Amortization	35.0	33.8	35.2	37.4	34.2	38.3	23.4	-798.8	15.8	12.1	10.6	2.6	2.7	2.7	2.7	2.8	2.2
Total Operating Expenses	214.3	214.3	178.7	84.3	140.4	136.1	147.3	114.7	81.4	67.7	58.5	37.8	34.7	27.3	26.9	25.3	51.8
Operating Income	47.2	47.2	-22.6	11.9	-25.5	78.9	8.6	-5.7	163.7	68.1	43.9	27.3	19.6	14.9	0.6	-0.7	-29.3

Operating Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	5.5
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	14.7
Depreciation & Amortization	9.6	8.1	8.5	8.8	8.6	9.0	8.9	8.8	9.4	8.9
Total Operating Expenses	65.6	35.7	36.3	76.7	49.6	36.2	76.0	16.9	29.8	28.4
Operating Income	20.0	54.9	8.4	-36.2	-9.6	3.1	-19.1	3.0	-3.4	-0.1

Net Income	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Interest Income	11.0	8.9	8.1	7.7	2.0	0.9	8.1	28.4	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4
Interest Expense	2.0	0.0	3.0	0.7	1.8	18.7	27.4	35.7	48.3	-11.4	-12.2	-11.8	-4.9	-2.1	-3.3	2.5	0.1
Other Expense	111.8	111.8	25.1	51.7	61.5	-31.6	-19.1	802.4	43.9	-10.8	-37.0	7.0	-9.4	-6.8	-4.8	-0.1	11.1
IBT	159.0	159.0	2.5	63.7	36.0	47.3	-10.5	796.6	173.3	57.2	8.0	35.3	11.3	9.2	-3.9	-2.9	-15.4
Income Tax Expense	34.5	34.5	6.6	9.8	41.2	-10.3	-7.6	167.3	30.0	44.7	10.3	-219.6	0.4	0.4	-1.2	-13.1	-2.6
Net Income	124.5	124.5	-4.0	52.2	-5.2	57.6	-3.0	629.3	143.3	12.6	-1.6	257.3	12.0	11.4	-0.5	10.2	-12.5

Net Income	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Interest Income	4.6	3.0	1.6	1.8	1.9	1.3	2.8	2.0	1.6	2.3
Interest Expense	0.0	0.0	1.2	0.9	0.9	0.7	1.3	0.1	0.1	0.0
Other Expense	36.7	86.2	2.8	-14.0	-29.6	-9.5	-46.3	110.5	20.5	-15.2
IBT	56.8	141.1	11.2	-50.2	-39.2	-6.3	-65.4	113.4	17.1	-15.3
Income Tax Expense	12.0	23.9	6.4	-7.7	-8.1	0.8	-13.5	27.3	-1.1	-2.6
Net Income	44.8	117.3	4.8	-42.5	-31.1	-7.2	-51.9	86.1	18.2	-12.8

Per Share Data	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
EPS	$0.00	$0.00	$0.00	$3.02	$-0.31	$3.44	$-0.18	$33.13	$6.77	$0.60	$-0.08	$13.00	$0.59	$0.56	$-0.03	$0.52	$-0.64
EPS Diluted	$0.00	$0.00	$0.00	$2.94	$-0.31	$3.31	$-0.18	$31.85	$5.96	$0.53	$-0.08	$12.12	$0.56	$0.55	$-0.03	$0.52	$-0.64
Shares Outstanding	19.7	19.3	18.3	17.3	16.9	16.6	16.2	19.0	21.2	21.0	20.8	19.8	20.4	20.3	19.9	19.7	19.6
Diluted Shares Outstanding	21.1	20.3	18.3	17.8	16.9	17.2	16.8	19.8	24.1	23.5	20.8	21.2	21.4	20.7	19.9	19.7	19.6

Per Share Data	TTM	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$1.04	$-0.74
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$1.03	$-0.74
Shares Outstanding	19.7	19.4	19.3	19.2	19.0	18.4	18.0	17.7	17.5	17.4
Diluted Shares Outstanding	21.1	20.2	19.9	19.2	19.0	18.4	18.0	18.1	17.7	17.4

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Cash And Equivalents	18.1	72.3	23.0	0.0	19.5	47.6	1,011.5	718.4	201.7	141.0	200.2	167.3	16.0	12.4	7.0	3.3
Short Term Investments	208.8	183.9	147.4	0.2	321.6	363.6	58.3	46.2	181.0	122.3	102.8	7.1	4.3	2.8	10.0	19.4
Total Cash & ST Investments	226.9	256.2	170.3	211.9	341.1	411.2	1,069.9	764.6	201.7	141.0	200.2	167.3	16.0	12.4	17.0	22.7
Accounts Receivable	37.5	42.4	39.3	35.0	91.6	59.1	41.7	55.9	29.5	17.9	11.0	13.0	6.6	8.9	6.1	1.0
Inventory	20.7	14.1	24.0	13.3	27.3	26.5	7.3	7.1	4.4	1.9	1.6	0.3	1.4	1.7	1.3	-22.7
Other Current Assets	27.1	18.8	3.8	3.4	4.7	3.8	4.7	20.4	1.5	2.2	2.8	4.6	1.0	0.8	24.8	36.0
Total Current Assets	312.3	331.6	237.4	263.6	464.8	500.6	1,123.6	870.5	237.0	163.1	215.6	185.2	24.9	23.8	32.2	37.0

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	139.4	67.7	48.0	72.3	63.6	18.1	50.1	23.0	19.3	219.0
Short Term Investments	525.1	187.6	160.9	183.9	156.0	208.8	260.5	147.4	171.2	190.6
Total Cash & ST Investments	664.5	255.3	208.9	256.2	219.6	226.9	310.6	170.3	190.5	219.0
Accounts Receivable	58.1	42.1	42.8	42.4	42.1	37.5	28.4	39.3	36.0	28.0
Inventory	11.9	12.9	11.8	14.1	13.4	14.5	21.3	24.0	25.4	26.9
Other Current Assets	19.4	42.6	45.8	18.8	34.2	33.4	8.5	3.8	2.1	2.8
Total Current Assets	753.9	352.9	309.3	331.6	309.4	312.3	368.9	237.4	257.8	276.7

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Property, Plant & Equipment	25.5	24.8	25.1	15.0	32.7	22.7	10.4	5.4	4.2	1.8	0.4	0.5	0.9	0.8	0.5	0.6
Goodwill	105.3	105.3	103.4	448.1	735.0	785.0	305.7	306.4	314.5	276.9	60.6	63.0	65.3	68.2	14.9	0.0
Intangible Assets	283.2	266.6	366.9	10.2	10.1	11.0	20.1	31.5	19.5	25.8	8.6	4.6	4.6	55.9	57.4	13.0
Long-Term Investments	47.7	10.9	48.3	0.0	0.0	0.0	-25.6	601.2	6.4	8.3	29.7	-0.3	5.8	8.2	1.3	1.3
Other Long-Term Assets	92.4	202.5	5.9	17.2	23.3	18.7	9.5	-600.7	4.9	1.7	2.6	4.9	1.6	3.3	15.8	23.3
Total Long-Term Assets	554.1	610.2	549.8	499.1	836.6	861.7	345.7	390.3	434.0	438.5	318.4	72.9	79.8	80.4	90.1	38.5
Total Assets	866.4	941.8	787.2	762.7	1,301.4	1,362.3	1,469.3	1,260.8	671.0	601.6	533.9	258.0	104.7	104.3	122.4	75.6

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	11.1	11.6	10.5	24.8	25.2	25.5	24.4	9.5	9.8	15.2
Goodwill	101.5	101.5	101.5	105.3	105.3	105.3	105.3	103.4	418.6	431.1
Intangible Assets	233.5	250.1	258.4	266.6	274.9	283.2	291.4	366.9	6.6	10.8
Long-Term Investments	42.0	204.5	199.2	195.9	212.4	93.7	112.7	48.3	47.2	0.0
Other Long-Term Assets	325.2	27.1	25.9	17.5	27.7	46.4	11.2	21.5	20.7	15.9
Total Long-Term Assets	722.9	595.7	596.1	610.2	645.5	554.1	545.0	595.6	511.4	481.4
Total Assets	1,476.8	948.6	905.4	941.8	954.9	866.4	913.9	833.1	769.2	758.1

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Accounts Payable	1.8	5.2	2.4	0.0	8.4	3.8	2.4	23.4	9.6	9.1	10.4	22.1	15.5	16.3	11.1	8.6
Short-Term Debt	1.2	1.3	0.4	77.4	0.0	6.6	1.2	26.4	224.5	212.9	0.9	0.3	9.1	14.8	16.2	8.0
Other Current Liabilities	14.4	27.5	12.7	21.0	22.2	60.3	11.2	29.1	4.5	5.1	10.4	0.2	4.2	3.8	15.1	17.3
Current Liabilities	18.6	37.1	16.8	98.8	41.7	100.1	17.0	82.2	238.9	227.1	20.8	22.8	28.9	35.4	43.6	35.6

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	27.8	8.6	5.4	5.2	4.7	1.8	1.9	2.4	2.5	9.6
Short-Term Debt	2.2	1.1	0.9	1.3	1.1	1.2	1.0	4.6	1.0	1.4
Other Current Liabilities	0.5	53.0	44.3	27.5	15.7	11.7	11.9	12.7	7.3	6.4
Current Liabilities	30.5	64.7	58.7	37.1	24.8	18.6	17.8	16.8	18.9	29.4

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Long-Term Debt	6.4	5.8	5.8	10.3	336.2	447.9	648.9	609.9	18.9	29.6	205.4	195.9	3.1	13.4	35.5	22.9
Capital Leases	6.4	7.1	6.2	11.1	15.5	12.2	10.0	0.0	0.0	0.0	0.9	3.3	5.9	9.0	8.4	11.1
Def. Tax Liability	30.1	32.5	0.0	30.6	62.4	64.6	7.3	0.0	-22.4	0.0	0.0	2.8	1.1	0.7	2.5	0.4
Total Liabilities	91.2	111.3	86.3	165.2	479.8	652.8	702.1	699.9	252.4	230.7	229.5	233.6	55.1	77.8	113.7	82.6

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	449.9	4.6	3.6	5.8	6.3	6.4	5.2	5.8	5.8	11.0
Capital Leases	5.5	5.7	4.4	7.1	7.4	7.6	6.2	5.8	6.3	11.7
Def. Tax Liability	22.7	32.2	29.4	32.5	46.4	30.1	50.6	77.5	31.9	27.7
Total Liabilities	526.6	120.1	109.9	111.3	113.7	91.2	107.3	130.7	103.8	93.2

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	537.2	499.0	503.0	0.5	449.1	392.0	400.1	-229.2	-400.9	-431.1	-402.0	-659.3	-671.3	-682.8	-681.8	-691.9
Comprehensive Income	-0.9	-5.9	-0.8	0.0	-0.9	-0.8	-0.2	-1.0	2.5	2.7	4.9	5.0	2.9	-4.9	0.0	0.0
Total Common Equity	775.2	830.4	700.9	597.5	821.6	709.5	767.2	560.9	418.6	370.9	304.4	26.3	49.6	26.5	8.6	-7.0

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Retained Earnings	578.2	461.4	456.5	499.0	530.1	537.2	589.2	503.0	484.8	495.1
Comprehensive Income	9.3	8.5	-1.6	-5.9	1.7	-0.9	-0.9	-0.8	-0.9	-1.0
Total Common Equity	950.2	828.5	795.5	830.4	841.2	775.2	806.5	700.9	665.4	664.9

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total Debt		7.6	7.1	6.2	87.7	336.3	454.5	648.9	636.3	224.5	212.9	205.4	196.2	9.1	28.3	51.7	30.9
Book Value		775.2	830.4	700.9	597.5	821.6	709.5	767.2	560.9	418.6	370.9	304.4	24.4	49.6	26.5	8.6	-7.0

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		950.2	828.5	795.5	830.4	841.2	775.2	806.5	700.9	665.4	664.9

Cash Flow From Operating Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Income	42.1	124.5	-4.0	52.2	-33.4	57.1	-3.0	629.3	143.3	12.6	-2.4	254.9	10.9	8.8	-2.7	10.2	-12.8
Depreciation & Amortization	36.1	35.7	35.2	35.6	51.4	50.9	28.0	43.7	14.7	11.7	11.3	2.6	2.7	2.7	2.7	2.8	2.2
Stock-Based Compensation	31.0	0.0	41.1	25.7	60.3	38.8	30.7	24.5	20.8	24.9	18.9	12.5	11.3	5.7	4.1	3.4	2.3
Change Working Capital	-36.2	-12.7	19.4	-34.4	65.7	-52.2	-10.1	-4.2	-38.9	-11.4	-10.6	0.8	-10.9	-0.7	-2.8	-5.9	-24.7
Change In Accounts Receivable	-10.7	-21.7	-6.5	-2.6	55.3	-28.6	-26.1	25.5	-29.5	-8.4	-8.5	6.5	-10.4	2.4	1.5	-3.9	-0.4
Change In Accounts Payable	0.6	5.9	0.0	-4.7	-3.3	-1.2	-1.2	-18.0	-4.5	-1.7	-2.4	-4.0	-3.2	-2.8	-4.8	-11.6	-13.4
Change In Inventories	5.2	5.0	9.6	-10.9	12.1	-0.4	-17.8	-2.1	-2.6	-0.8	-0.2	-0.4	4.4	0.6	1.0	1.1	-3.9
Other Non-cash Items	18.5	-120.8	21.2	-41.3	-26.8	-7.3	28.0	-797.5	24.3	11.3	35.1	-9.5	6.3	3.9	0.0	1.6	-0.1
Cash from Operations	47.7	0.0	0.0	49.6	137.9	78.8	54.6	-29.3	194.1	93.6	63.0	41.7	20.6	20.7	0.2	-1.2	-27.1

Cash Flow From Operating Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Income	44.8	117.3	4.8	-42.5	-31.1	-7.2	-51.9	86.1	18.2	-10.3
Depreciation & Amortization	9.6	6.9	8.9	9.3	8.6	7.3	8.9	8.8	8.9	8.5
Stock-Based Compensation	14.3	14.7	0.0	0.0	7.5	26.2	11.1	7.3	5.7	6.9
Change Working Capital	9.3	-10.6	-6.2	-5.2	11.6	-0.6	-7.6	8.2	-16.0	-20.8
Change In Accounts Receivable	-2.1	-16.3	-2.8	-0.6	-5.7	4.8	-9.0	3.5	2.8	-7.9
Change In Accounts Payable	7.3	1.1	-0.4	-2.1	11.3	2.2	0.0	-1.4	1.8	-1.6
Change In Inventories	2.8	3.6	-0.9	-0.5	2.6	1.9	2.5	2.6	0.7	-0.6
Other Non-cash Items	-23.3	-124.0	8.5	21.6	44.5	12.8	73.6	-111.3	-13.7	15.3
Cash from Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	7.6

Cash Flow From Investing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Capital Expenditure	-53.5	-11.3	-1.8	-3.5	-17.9	-8.8	-4.5	-2.6	-11.9	-7.2	-28.3	-10.9	-4.5	-4.9	-8.6	-0.1	-0.1
Acquisitions	-101.7	-8.1	-172.2	-10.4	-0.8	0.5	-383.3	-12.8	-5.9	-26.7	-94.2	-9.2	0.0	0.0	0.0	-32.0	-2.8
Investments	-139.9	-730.9	-226.4	-126.8	-51.2	-181.3	-422.5	-2,356.5	-1,434.3	-254.3	-164.4	-166.0	0.0	0.0	0.0	-10.0	-35.6
Sales of Investment	207.2	377.3	269.6	194.2	234.4	221.3	1,038.7	2,030.7	1,024.8	196.6	143.5	73.3	2.3	0.0	10.0	19.3	54.0
Other Investing Activities	-75.5	0.0	0.0	-65.2	-0.9	-1.2	3.3	808.1	3.9	7.3	0.3	0.0	0.1	0.0	-0.1	-2.4	-1.0
Cash from Investing	-88.3	0.0	0.0	-11.7	163.6	30.5	231.6	466.9	-423.3	-84.2	-143.2	-112.9	-2.0	-5.0	1.3	-25.1	14.5

Cash Flow From Investing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Capital Expenditure	0.0	0.0	-0.2	-2.0	-0.7	3.6	-0.4	-0.1	-50.7	-0.5
Acquisitions	0.0	0.0	0.0	0.0	80.2	-96.2	-75.0	-1.0	0.0	-25.6
Investments	-211.9	-392.1	-63.3	-59.4	-97.0	-4.8	-24.4	-77.6	-19.5	-18.3
Sales of Investment	202.2	53.5	50.9	70.8	45.2	94.8	47.1	75.5	59.9	24.8
Other Investing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1
Cash from Investing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-10.3	-19.5

Cash Flow From Financing Activities	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Debt Repaid	-0.1	0.0	0.0	-76.9	-261.0	-164.9	-231.8	-27.3	-217.7	0.0	0.0	0.0	-9.4	-19.6	-10.0	0.0	-0.1
Debt Issued	-4.0	7.1	0.9	-4.7	12.5	46.7	37.4	40.0	629.4	11.6	7.5	9.1	196.5	0.4	-13.5	20.9	31.0
Issuance of Common Stock	39.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.4	0.1	0.0
Repurchase of Common Stock	-3.4	-15.0	0.0	-4.5	0.0	0.0	-78.0	-453.0	-122.9	-2.0	-3.9	-0.5	-68.0	0.0	0.0	-0.1	-0.1
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	5.9	0.0	0.0	17.0	-15.0	27.2	-0.8	-4.8	669.1	-5.6	5.4	8.8	207.3	3.0	8.5	30.0	0.0
Cash from Financing	30.4	0.0	0.0	-59.9	-276.0	-137.8	-310.5	-485.2	328.6	-7.5	1.5	8.4	130.0	-16.5	3.9	30.0	-0.2

Cash Flow From Financing Activities	4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	4-2023	3-2023
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Debt Issued	451.0	445.3	1.3	-2.7	-0.3	-0.2	1.4	-0.2	-5.3
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	7.6
Repurchase of Common Stock	0.0	-15.0	0.0	0.0	0.0	0.0	0.0	-0.3	-0.1
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	3.2
Cash from Financing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.3

Cash position		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Change in Cash		-10.3	102.6	49.4	-22.1	25.5	-28.4	-24.3	-47.5	99.2	1.9	-78.7	-62.8	148.6	-0.7	5.3	3.7	-12.7
Closing Cash Balance		18.1	174.9	72.3	23.0	45.0	19.5	48.0	72.3	119.8	20.6	18.8	97.4	160.2	11.6	12.4	7.0	3.3

Cash position		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Net Change in Cash		35.6	71.7	19.7	-24.3	8.7	45.5	-32.0	27.1	3.1	-8.6
Closing Cash Balance		174.9	139.4	67.7	48.0	72.3	63.6	18.1	50.1	23.0	19.9

Free Cash Flow		TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Free Cash Flow		-5.8	48.9	77.4	-4.3	119.9	70.0	50.1	-31.9	182.2	86.4	34.7	30.9	16.1	15.8	-8.5	-1.3	-27.1
Real Free Cash Flow		-36.8	48.9	36.3	-30.0	59.6	31.3	19.4	-56.4	161.3	61.5	15.8	18.4	4.8	10.1	-12.6	-4.6	-29.5

Free Cash Flow		4-2025	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023
Free Cash Flow		45.8	13.1	15.6	-25.7	27.8	22.3	11.2	18.6	-42.7	7.2
Real Free Cash Flow		31.6	-1.7	15.6	-25.7	20.2	-3.9	0.1	11.3	-48.4	0.3